» Authors » Maxime Touzot

Maxime Touzot

Explore the profile of Maxime Touzot including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 860
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bannier P, Saillard C, Mann P, Touzot M, Maussion C, Matek C, et al.
Nat Commun . 2024 Dec; 15(1):10914. PMID: 39738108
Pathogenic activating mutations in the fibroblast growth factor receptor 3 (FGFR3) drive disease maintenance and progression in urothelial cancer. 10-15% of muscle-invasive and metastatic urothelial cancer (MIBC/mUC) are FGFR3-mutant. Selective...
2.
Michon-Colin A, Lombardi Y, Seret G, Lavainne F, Testa A, Ayari H, et al.
J Nephrol . 2024 Dec; PMID: 39674977
No abstract available.
3.
Lanot A, Misery L, Rostoker G, Testa A, Chauveau P, Touzot M, et al.
Nephrol Ther . 2024 Jan; 20(1):50-60. PMID: 38294264
Chronic kidney disease-associated pruritus (CKD-aP) is a disabling symptom which is frequent and often underestimated. Pa-MRC has a negative impact on quality of life, and is frequently accompanied by sleep...
4.
Touzot M, Bataille P, Rostoker G, Chauveau P, Lanot A, Misery L
Nephrol Ther . 2023 Nov; 19(6):475-482. PMID: 37915193
Background: Chronic kidney disease-associated pruritus (CKD-aP) is common in hemodialysis patients and severely impairs their quality of life, but the practices of nephrologists remain poorly known. Methods: The objective of...
5.
Lanot A, Bataille S, Rostoker G, Bataille P, Chauveau P, Touzot M, et al.
Clin Kidney J . 2023 Jul; 16(7):1102-1112. PMID: 37398693
Background: Chronic kidney disease-associated pruritus (CKD-aP) is a common condition in patients treated with hemodialysis, and has a negative impact on quality of life (QoL). Due to the lack of...
6.
Azancot S, Urena-Torres P, Chazot C, Touzot M
Nephrol Ther . 2022 Dec; 18(6S1):6S11-6S16. PMID: 36585120
Chronic Kidney Disease associated Pruritus (CKD-aP) is a well-established and frequent complication observed in patient with CKD, especially in dialysis patients. However, the management of CKD-aP remains a challenge as...
7.
Touzot M, Reach P, Mobio A, Sacco E, Fels A, Beaussier H, et al.
Kidney Int Rep . 2022 Dec; 7(12):2734-2736. PMID: 36506235
No abstract available.
8.
Touzot M, Urena-Torres P, Dupuy O
Clin Kidney J . 2022 Aug; 15(9):1782-1784. PMID: 36003674
Obesity limits the access to kidney transplantation and increases the risk of complications and mortality posttransplantation. Usual noninvasive measures, including lifestyle changes and dietary education, do not provide long-term and...
9.
Azancot S, Urena-Torres P, Touzot M
Kidney Int Rep . 2022 Jul; 7(7):1447-1449. PMID: 35812264
No abstract available.
10.
Lombardi Y, Ridel C, Touzot M
Clin Kidney J . 2022 Mar; 14(2):471-473. PMID: 35261757
Acute kidney injury (AKI) is a common disorder that complicates the hospital course of many patients. AKI is linked with an independent risk of death, hospital length of stay and...